CRM vs TTRX · P/E 41, rev $11.35B vs $187.1M cap
Salesforce.com Inc (CRM) versus Turn Therapeutics Inc. Common Stock (TTRX) — a side-by-side from cached financials, not a winner call.
Salesforce.com Inc (CRM) is a software - application company listed on US. It is led by Marc Benioff.
Turn Therapeutics Inc. Common Stock (TTRX) is a biotechnology company listed on NASDAQ.
Latest reported CRM revenue for 2026-07-31 was $11.35B. Net income was $3.53B. Revenue was up 1.9% from 2026-04-30 to 2026-07-31. CRM currently screens at market cap $252.36B and trailing P/E 41.3.
TTRX does not have a complete income-statement cache yet.
CRM currently screens at market cap $252.36B and trailing P/E 41.3. TTRX currently screens at market cap $187.1M.
Not investment advice. Open the CRM and TTRX stock pages for the full models.
Not investment advice.